Please ensure Javascript is enabled for purposes of website accessibility

Google-Supported Telehealth Company Amwell Prices IPO

By Eric Volkman – Sep 8, 2020 at 10:37PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company should reap up to $560 million in gross proceeds from the issue.

A company firmly placed in the burgeoning telehealth segment -- privately held Amwell -- has outlined the terms of its upcoming initial public offering (IPO) in a regulatory document filed on Tuesday.

The company aims to sell 35 million shares of its Class A common stock at a price between $14 and $16 per share. This would bring in gross proceeds of $490 million to $560 million. Amwell will utilize those monies "for working capital and other general corporate purposes," which could cover a range of uses. The company specifically mentioned boosting research and development, and expanding its sales team, among other purposes.

Doctor and patient conferring via tablet computer.

Image source: Getty Images.

Amwell delivers telemedicine services through its proprietary Amwell Platform. With this, it says, as of the end of June it had provided the digital health programs of 55 insurance plans, which in turn covered more than 36,000 businesses employing over 80 million people. Amwell Platform was also in use at 150 of the top health systems in the U.S.; this covers more than 2,000 hospitals.

Since the platform's launch, according to Amwell, it has been the conduit for 5.6 million virtual visits by patients. Over 2.9 million of these took place in the first six months of this year.

While Amwell is loss-making, its revenue has increased dramatically of late, advancing 77% year over year in that six months to more than $122 million.

Last month, Alphabet's (GOOG 0.02%) (GOOGL -0.01%) Google Cloud unit said it would invest $100 million into the Class C shares of Amwell. Alphabet's investment is to be made concurrent with the IPO. In return, Google Cloud is to become the "preferred global cloud platform partner," of the company. The two businesses will combine to develop cutting-edge technologies in the telehealth field.

Amwell has not yet set its IPO date.

Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Alphabet (A shares) and Alphabet (C shares). The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Alphabet Inc. Stock Quote
Alphabet Inc.
GOOGL
$101.42 (-0.01%) $0.01
Alphabet Inc. Stock Quote
Alphabet Inc.
GOOG
$102.24 (0.02%) $0.02

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
339%
 
S&P 500 Returns
109%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/07/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.